Skip to main content
Clinical Trials/NCT03303664
NCT03303664WithdrawnNot Applicable

Inpatient Multimodal Path to RecOVEry

Wake Forest University Health Sciences24 sites in 1 countryStarted: July 11, 2017Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Withdrawn
Locations
24
Primary Endpoint
Use of Opioid Overdose Reversal Treatment

Study Overview

Brief Summary

The goal of the proposed study is to develop and implement a comprehensive strategy to address pain management in the inpatient setting while appropriately managing pain and optimizing patient safety in the inpatient setting. This strategy involves developing a new health Information Technology tool in the Omnicell and electronic medical record, implementing a "menu" of pain management and relaxation strategies, and developing educational materials for staff and patients to change the culture of pain management.

Detailed Description

The goal of the proposed study is to develop and implement a comprehensive strategy to address pain management in the inpatient setting while appropriately managing pain and optimizing patient safety in the inpatient setting. This strategy involves developing a new health Information Technology tool in the Omnicell and electronic medical record, implementing a "menu" of pain management and relaxation strategies, and developing educational materials for staff and patients to change the culture of pain management.

This intervention will be implemented throughout CHS hospitals, using a stepped wedge design to guide rollout. The initial pilot will be conducted in the trauma inpatient units at Carolinas Medical Center. All patients admitted to the two primary trauma units (11A and 11 Tower) during the pilot study period will be included in the evaluation.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Health Services Research
Masking
None

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • All patients treated in facility as inpatient during the study period will be included in the analysis.

Exclusion Criteria

  • Patients not admitted to facility during the study period will be excluded from the analysis.

Outcomes

Primary Outcomes

Use of Opioid Overdose Reversal Treatment

Time Frame: Patient's entire length of stay in the hospital, up to 3 months

Incidence of administration of opioid reversal agent

Secondary Outcomes

  • Multimodal Therapy(Patient's entire length of stay in the hospital, up to 3 months)
  • Pain(Patient's entire length of stay in the hospital, up to 3 months)
  • Oversedation without naloxone(Patient's entire length of stay in the hospital, up to 3 months)
  • Average Daily MME(Patient's entire length of stay in the hospital, up to 3 months)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (24)

Loading locations...

Similar Trials